Chesterfield, MO, United States of America

Angela Sutterer

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: Flamel Ireland Limited, Avadel Legacy Pharmaceuticals, LLC, Exela Sterile Medicines LLC. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela Sutterer. Retrieved from https://idiyas.com/inventor/angela-sutterer-izj0w15f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Angela Sutterer: Pioneering Innovations in Chesterfield

Introduction: Angela Sutterer is a visionary inventor based in Chesterfield, Missouri, known for her groundbreaking contributions to various industries.

Latest Patents: Angela Sutterer holds several patents in the fields of healthcare technology, renewable energy, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Angela has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have transformed the way we live and work.

Collaborations: Throughout her career, Angela has collaborated with leading research institutions, universities, and companies to bring her inventions to life, fostering a culture of creativity and excellence in the industry.

Conclusion: Angela Sutterer's passion for innovation and relentless pursuit of excellence continue to inspire the next generation of inventors, leaving an indelible mark on the world of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…